The Discounted Cash Flow (DCF) valuation of FibroGen Inc (FGEN) is (41.05) USD. With the latest stock price at 9.51 USD, the upside of FibroGen Inc based on DCF is -531.7%.
Based on the latest price of 9.51 USD and our DCF valuation, FibroGen Inc (FGEN) is a sell. selling FGEN stocks now will result in a potential gain of 531.7%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 20.7% | 13.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,090.07) - (10.68) | (41.05) |
| Upside | -11562.3% - -212.3% | -531.7% |